ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/12/03 | 2,152 | 2,157 | 2,029 | 2,104 | -74 | -3.4% | 185,900 |
2019/12/02 | 2,160 | 2,183 | 2,160 | 2,178 | +18 | +0.8% | 49,500 |
2019/11/29 | 2,163 | 2,174 | 2,146 | 2,160 | +9 | +0.4% | 64,300 |
2019/11/28 | 2,166 | 2,166 | 2,130 | 2,151 | -7 | -0.3% | 66,700 |
2019/11/27 | 2,144 | 2,176 | 2,140 | 2,158 | +31 | +1.5% | 67,700 |
2019/11/26 | 2,187 | 2,188 | 2,124 | 2,127 | -33 | -1.5% | 94,200 |
2019/11/25 | 2,148 | 2,169 | 2,144 | 2,160 | +29 | +1.4% | 58,300 |
2019/11/22 | 2,144 | 2,146 | 2,123 | 2,131 | +6 | +0.3% | 47,700 |
2019/11/21 | 2,130 | 2,137 | 2,091 | 2,125 | +10 | +0.5% | 52,000 |
2019/11/20 | 2,110 | 2,124 | 2,093 | 2,115 | +25 | +1.2% | 28,900 |
2019/11/19 | 2,064 | 2,102 | 2,064 | 2,090 | +13 | +0.6% | 40,500 |
2019/11/18 | 2,071 | 2,090 | 2,055 | 2,077 | -3 | -0.1% | 43,400 |
2019/11/15 | 2,073 | 2,094 | 2,072 | 2,080 | +23 | +1.1% | 44,700 |
2019/11/14 | 2,070 | 2,088 | 2,042 | 2,057 | -19 | -0.9% | 49,400 |
2019/11/13 | 2,113 | 2,124 | 2,076 | 2,076 | -34 | -1.6% | 144,600 |
2019/11/12 | 2,137 | 2,137 | 2,109 | 2,110 | -29 | -1.4% | 73,800 |
2019/11/11 | 2,132 | 2,146 | 2,121 | 2,139 | +7 | +0.3% | 61,000 |
2019/11/08 | 2,140 | 2,140 | 2,094 | 2,132 | +8 | +0.4% | 122,200 |
2019/11/07 | 2,139 | 2,139 | 2,102 | 2,124 | +18 | +0.9% | 75,200 |
2019/11/06 | 2,100 | 2,113 | 2,065 | 2,106 | -1 | ±0% | 78,300 |
2019/11/05 | 2,060 | 2,129 | 2,030 | 2,107 | +70 | +3.4% | 150,300 |
2019/11/01 | 2,060 | 2,071 | 2,027 | 2,037 | -13 | -0.6% | 63,000 |
2019/10/31 | 2,040 | 2,058 | 2,034 | 2,050 | +5 | +0.2% | 70,200 |
2019/10/30 | 2,014 | 2,050 | 2,000 | 2,045 | +25 | +1.2% | 184,300 |
2019/10/29 | 2,015 | 2,022 | 2,002 | 2,020 | +29 | +1.5% | 87,200 |
2019/10/28 | 1,993 | 2,002 | 1,976 | 1,991 | -2 | -0.1% | 81,500 |
2019/10/25 | 1,984 | 1,995 | 1,969 | 1,993 | +9 | +0.5% | 94,800 |
2019/10/24 | 1,986 | 1,992 | 1,963 | 1,984 | +18 | +0.9% | 65,000 |
2019/10/23 | 1,944 | 1,966 | 1,926 | 1,966 | +35 | +1.8% | 52,600 |
2019/10/21 | 1,945 | 1,949 | 1,926 | 1,931 | -14 | -0.7% | 35,500 |
2019/10/18 | 1,946 | 1,974 | 1,940 | 1,945 | -5 | -0.3% | 53,600 |
2019/10/17 | 1,951 | 1,954 | 1,932 | 1,950 | +1 | +0.1% | 61,100 |
2019/10/16 | 1,957 | 1,968 | 1,937 | 1,949 | +19 | +1% | 85,500 |
2019/10/15 | 1,925 | 1,938 | 1,918 | 1,930 | +35 | +1.8% | 61,400 |
2019/10/11 | 1,908 | 1,915 | 1,892 | 1,895 | -5 | -0.3% | 72,100 |
2019/10/10 | 1,895 | 1,905 | 1,868 | 1,900 | +5 | +0.3% | 67,200 |
2019/10/09 | 1,892 | 1,906 | 1,882 | 1,895 | -11 | -0.6% | 71,500 |
2019/10/08 | 1,896 | 1,911 | 1,885 | 1,906 | +21 | +1.1% | 76,200 |
2019/10/07 | 1,863 | 1,885 | 1,859 | 1,885 | +14 | +0.7% | 50,200 |
2019/10/04 | 1,860 | 1,873 | 1,840 | 1,871 | +10 | +0.5% | 71,200 |
2019/10/03 | 1,873 | 1,873 | 1,849 | 1,861 | -43 | -2.3% | 57,100 |
2019/10/02 | 1,905 | 1,926 | 1,894 | 1,904 | -8 | -0.4% | 65,000 |
2019/10/01 | 1,891 | 1,923 | 1,891 | 1,912 | +14 | +0.7% | 61,000 |
2019/09/30 | 1,883 | 1,899 | 1,876 | 1,898 | -8 | -0.4% | 94,500 |
2019/09/27 | 1,947 | 1,952 | 1,884 | 1,906 | -57 | -2.9% | 112,900 |
2019/09/26 | 1,966 | 1,995 | 1,956 | 1,963 | +2 | +0.1% | 210,300 |
2019/09/25 | 1,952 | 1,965 | 1,937 | 1,961 | +4 | +0.2% | 93,200 |
2019/09/24 | 1,958 | 1,991 | 1,954 | 1,957 | +6 | +0.3% | 131,400 |
2019/09/20 | 1,940 | 1,955 | 1,921 | 1,951 | +15 | +0.8% | 119,200 |
2019/09/19 | 1,920 | 1,944 | 1,920 | 1,936 | +31 | +1.6% | 106,300 |
1401~
1450
件表示中 / 3770件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 203,500円 | +3.1% | -6.5% | 2.36% | 9.44倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 264,800円 | +21.7% | +999.9% | 0.00% | 12.20倍 | 4.18倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 315,000円 | +5.1% | -7.0% | 2.54% | 20.68倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 246,500円 | +4.1% | -3.1% | 2.35% | 21.41倍 | 1.86倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
杏林製薬 | 152,300円 | -2.4% | -52.3% | 3.74% | 18.23倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム